Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2002 | Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma | CHIUN HSU ; Huang, Chiun-Sheng; Chao, Tsu-Yi; Lu, Yen-Shen; Bu, Ching-Fang; Chen, Mary M; Chang, King-Jeng; Cheng, Ann-Lii | Cancer | 12 | 11 | |
2007 | Phase Ii Trial of the Efficacy and Safety of Sunitinib Malate Monotherapy in Unresectable Hepatocellular Carcinoma | CHENG, ANN-LII; 鄭安理 | ANNALS OF ONCOLOGY | | | |
2015 | Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC) | Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Journal of Clinical Oncology | 0 | 0 | |
2013 | Potential synergistic antitumor activity between sorafenib and lenalidomide in an orthotopic murine liver cancer model. | Chang, Chun-Jung; Ou, Da-Liang; Lin, Yi-Jang; Cheng, Ann-Lii; Hsu, Chiun; 鄭安理 | Cancer Res. | 0 | 0 | |
2013 | Prevalence of gene amplifications of SOX-2, c-MET, and FGFR1 in Asian patients with esophageal squamous cell carcinoma. | Huang, Ta-Chen; Chen, Wei-Wu; Hsu, Ta-Wen; Lin, Chia-Chi J.; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | J. Clin. Oncol. | | | |
2015 | Randomized study of tailored neoadjuvant chemotherapy according to the expression of tau, topo II alpha, and ERCC1 versus standard chemotherapy in HER2-negative breast cancer | Lu, Yen-Shen; Yeh, Dah-Cherng; Tseng, Ling-Ming; Chen, Shou-Tung; Lien, Huang-Chun; Chang, Hong-Tai; Chang, Yuan-Ching; Huang, Shu-Min; Lin, Ching-Hung; Cheng, Ann-Lii; Huang, Chiun-Sheng; 鄭安理 | J. Clin. Oncol. | | | |
2003 | Rapidly Changing Incidence and Age-Distribution of Female Breast Cancer in Taiwan during 1980-1999 | CHANG, CHEE-JEN; CHENG, ANN-LII | CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION v.12 n.11 pp.1292S-1292 S | | | |
2014 | Reply: To PMID 24002804 | CHIUN HSU ; Chen, Pei-Jer; Cheng, Ann-Lii | Hepatology (Baltimore, Md.) | | | |
1998 | Research Nurses for Clinical Trials of Anti-Cancer Drugs: Developing a New Subspecialty in Taiwan | CHENG, ANN-LII; LAI, YEUR-HUR; YU, YU-CHIEH; 鄭安理 | DRUG INFORMATION JOURNAL | | | |
1994 | Retinoic Acid-Induced Apoptosis and Regression of a Refractory EB Virus-Containing T Cell Lymphoma Expressing Multidrug-Resistance Phenotypes | Cheng, Ann-Lii; Lay, J. D.; Su, I. J.; 鄭安理 | British Journal of Haematology | | | |
2000 | Retinoic Acid-Induced Apoptotic Pathway in T-Cell Lymphmoa : Identification of Four Groups of Genes with Differential Biological Function | WANG, KAO-CHUNG; CHENG, ANN-LII; CHUANG, SHUANG-EN; HSU, HEY-CHI; SU, IH-JEN; 鄭安理 | EXPERIMENTAL HEMATOLOGY | | | |
2005 | Significant Difference in the Trends of Female Breast Cancer Incidence between Taiwanese and Caucasian Americans: Implications from Age-Period- Cohort Analysis | SHEN, YING-CHUN; CHANG, CHEE-JEN; HSU, CHIUN; CHENG, ANN-LII | CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION v.14 n.8 pp.1986-1990 | | | |
2008 | Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc) Subgroup Analysis of Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and Ecog Performance Status on Outcome | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | HEPATOLOGY | | | |
2008 | Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemonaive NSCLC patients receiving first-line gefitinib monotherapy | Yang, Chih-Hsin; Yu, Chong-Jen; Shih, Jin-Yuan; Chang, Yeun-Chung; Hu, Fu-Chang; Tsai, Meng-Chin; Chen, Kuan-Yu; Lin, Zhong-Zhe; Huang, Ching-Ju; Shun, Chia-Tung; Huang, Chin-Lun; Bean, James; Cheng, Ann-Lii; Pao, William; Yang, Pan-Chyr | J Clin Oncol | | | |
2003 | Steroid-Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv-Carriers with Lymphoma | CHENG, ANN-LII; SU, IH-JEN; TIEN, HWEI- FANG; 鄭安理 | HEPATOLOGY | | | |
2003 | Steroid-Tree Chemotherapy Decreases Hepatitis B Virus (Hbv) Reactivation in Hbv-Carrier Lymphoma Patients | CHENG, ANN-LII; HSIUNG, CHAO A.; SU, IH-JEN; CHEN, PEI-JER; CHANG, MING-CHIH; TSAO, CHAO-JUNG; KAO, WOEI-YAU; UEN, WU-CHING; HSU, CHIH-HUNG; TIEN, HWEI-FANG; CHAO, TSU -YI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE; 鄭安理; 陳培哲 | HEPATOLOGY | | | |
2007 | Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinorna Cells Expressing Axl | LAY, JONG-DING; HUANG, JHY-SHRIAN; LAI, GI-MING; CHENG, ANN-LII; SU, IH-JEN; CHUANG, SHUANG-EN; 鄭安理 | CANCER RESEARCH | | | |
1993 | Test Dose Guided Rapid IV Suramine Infusions with Weekly IV Maintenance Doses | Arzoomanian, R.; Rago, R.; Cheng, Ann-Lii; Tombes, M. B.; Alberti, D.; Tusch, K.; Mutch, R.; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
2015 | The use of opioids not recommended in guidelines in Taiwan cancer patients. | Hsiue, Han-Chung Emily; Lin, Chih-Peng; Lin, Wen-Ying; Chen, Ho-Min; Cheng, Ann-Lii; Lai, Mei-Shu; Shao, Yu Yun | J. Clin. Oncol. | | | |
2015 | The use of opioids not recommended in guidelines in Taiwan cancer patients. | Hsiue, Han-Chung Emily; Lin, Chih-Peng; Lin, Wen-Ying; Chen, Ho-Min; Cheng, Ann-Lii; Lai, Mei-Shu; Shao, Yu Yun | J. Clin. Oncol. | | | |